Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab Matthew CranerYaser Al MalikHazem Wahba Commentary Open access 01 September 2022 Pages: 1457 - 1473
Expert-Agreed Practical Recommendations on the Use of Cladribine Virginia Meca-LallanaJosé M. García DomínguezJaume Sastre-Garriga Commentary Open access 06 September 2022 Pages: 1475 - 1488
Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review Javier QuinteroJosé R. Gutiérrez-CasaresCecilio Álamo Review Open access 11 August 2022 Pages: 1489 - 1517
Outcomes of Endovascular Therapy in Young Patients with Acute Basilar Artery Occlusion: A Substudy of BASILAR Registry Study Jinrong HuXing LiuDe Yang Original Research Open access 16 June 2022 Pages: 1519 - 1532
Correction to: Outcomes of Endovascular Therapy in Young Patients with Acute Basilar Artery Occlusion: A Substudy of BASILAR Registry Study Jinrong HuXing LiuDe Yang Correction Open access 05 August 2022 Pages: 1533 - 1534
Physician-Reported Perspectives on Myasthenia Gravis in the United States: A Real-World Survey Milada MahicAli M. BozorgAnna Scowcroft Original Research Open access 20 July 2022 Pages: 1535 - 1551
Autologous Hematopoietic Stem-Cell Transplantation in Multiple Sclerosis: A Systematic Review and Meta-Analysis Fardin NabizadehKasra PiraheshOmid Mirmosayyeb Original Research Open access 28 July 2022 Pages: 1553 - 1569
Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel Rajesh PahwaStuart H. IsaacsonMarwan Sabbagh Original Research Open access 29 July 2022 Pages: 1571 - 1582
Effect of Concurrent Use of Memantine on the Efficacy of Masupirdine (SUVN-502): A Post Hoc Analysis of a Phase 2 Randomized Placebo-Controlled Study Ramakrishna NirogiVinod Kumar GoyalJeffrey Cummings Original Research Open access 31 July 2022 Pages: 1583 - 1594
Three Newly Recognized Likely Pathogenic Gene Variants Associated with Hereditary Transthyretin Amyloidosis Jignesh K. PatelAndrew M. RosenArvind Narayana Original Research Open access 06 August 2022 Pages: 1595 - 1607
A Simulation Model to Evaluate the Potential Impact of Disease-Modifying Treatments on Burden of Illness in Alzheimer’s Disease Amir Abbas Tahami MonfaredAli TafazzoliQuanwu Zhang Original Research Open access 12 August 2022 Pages: 1609 - 1623
Neuroanatomy and Functional Connectivity in Patients with Parkinson’s Disease with or without Restless Legs Syndrome Qiu Ling ZangJin Hua ZhengWang Miao Original Research Open access 23 August 2022 Pages: 1625 - 1636
Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients Michael FleischerFabian SzepanowskiChristoph Kleinschnitz Original Research Open access 26 August 2022 Pages: 1637 - 1657
Risk of Major Cardiovascular and Cerebrovascular Events in Users of Lisdexamfetamine and Other Medications for Attention-Deficit/Hyperactivity Disorder in Denmark and Sweden: A Population-Based Cohort Study Joan FornsElena DudukinaCristina Rebordosa Original Research Open access 26 August 2022 Pages: 1659 - 1676
Circulating Insulin-Like Growth Factor 1 Levels and Migraine Risk: A Mendelian Randomization Study Reziya AbuduxukuerPeng-Peng NiuYi Yang Original Research Open access 01 September 2022 Pages: 1677 - 1689
Effectiveness of Training Programs for Reducing Adverse Psychological Outcomes in Parents of Children with Acquired Brain Injury: A Systematic Review and Meta-Analysis Kerri L. LaRovereYuzhe TangGuang Yang Original Research Open access 01 September 2022 Pages: 1691 - 1704
Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations Michael C. SmithPavel KleinWilliam E. Rosenfeld Original Research Open access 03 September 2022 Pages: 1705 - 1720
Rapid Onset and Sustained Efficacy of Lasmiditan Among Japanese Patients with Migraine: Prespecified Analyses of a Randomized Controlled Trial Yasuhiko MatsumoriMika KomoriFumihiko Sakai Original Research Open access 22 September 2022 Pages: 1721 - 1734
Persistence, Adherence, and Switching to Higher-Cost Therapy in Patients with Multiple Sclerosis Initiating Oral Disease-Modifying Therapies: A Retrospective Real-World Study Lita AraujoSvend S. GeertsenJanneke van Wingerden Original Research Open access 24 September 2022 Pages: 1735 - 1748
Verifynow P2Y12 PRU-Guided Modification of Clopidogrel for Prevention of Recurrent Ischemic Stroke: A Real-World Prospective Cohort Study Yuanjin ZhangDongsheng FanHongtao Hu Original Research Open access 26 September 2022 Pages: 1749 - 1766
Integrative Analyses Identify KCNJ15 as a Candidate Gene in Patients with Epilepsy Shitao WangZongyou LiLili Dai Original Research Open access 28 September 2022 Pages: 1767 - 1776
Evaluation of Diffusion–Perfusion Mismatch in Acute Ischemic Stroke with a New Automated Perfusion-Weighted Imaging Software: A Retrospective Study Yunyun XiongYu LuoYongjun Wang Original Research Open access 06 October 2022 Pages: 1777 - 1788
Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study Simona LattanziLaura CanafogliaBRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) Group Brief Report Open access 16 September 2022 Pages: 1789 - 1804
Elderly-Onset Paroxysmal Kinesigenic Dyskinesia: A Case Report Lulu YaoWei LiangXiaobo Huang Case Report Open access 17 September 2022 Pages: 1805 - 1811